User menu

A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors.

Bibliographic reference Vermorken, J B ; Rottey, S ; Ehrnrooth, E ; Pelling, K ; Lahogue, A ; et. al. A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors.. In: Annals of Oncology, Vol. 24, no.5, p. 1392-1400 (2013)
Permanent URL http://hdl.handle.net/2078.1/140353